[HTML][HTML] Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility
…, G Perri, P Fusco, V Scaglione, C Davoli, R Lionello… - Scientific reports, 2020 - nature.com
Since December 2019, coronavirus disease 2019 (COVID-19) pandemic has spread from
China all over the world and many COVID-19 outbreaks have been reported in long-term care …
China all over the world and many COVID-19 outbreaks have been reported in long-term care …
[HTML][HTML] Efficacy of cefiderocol-vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant …
…, S Gullì, C Borrazzo, A Quirino, R Lionello… - International journal of …, 2023 - Elsevier
Introduction Ventilator-associated pneumonia (VAP) caused by carbapenem-resistant
Acinetobacter baumannii (CRAB) in patients hospitalized in intensive care units (ICUs) is an …
Acinetobacter baumannii (CRAB) in patients hospitalized in intensive care units (ICUs) is an …
Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae …
…, A Bruni, E Biamonte, R Lionello… - Journal of …, 2019 - academic.oup.com
Sir, Cefiderocol is a new siderophore cephalosporin, with potent activity against MDR Gram-negative
bacilli. It is particularly active against XDR Acinetobacter baumannii (Ab) infections, …
bacilli. It is particularly active against XDR Acinetobacter baumannii (Ab) infections, …
[HTML][HTML] Use of subcutaneous tocilizumab in patients with COVID‐19 pneumonia
…, MC Pelle, B Tassone, R Lionello… - Journal of medical …, 2021 - ncbi.nlm.nih.gov
To the Editor, Di Giambenedetto et al. 1 described their experience with intravenous tocilizumab
(TCZ) in treating severe coronavirus disease 2019 (COVID‐19). This adds to several …
(TCZ) in treating severe coronavirus disease 2019 (COVID‐19). This adds to several …
[HTML][HTML] SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections
…, AM Tolomeo, V Dattilo, R Lionello… - Clinical Chemistry and …, 2023 - degruyter.com
Objectives Nearly three years into the pandemic, SARS-CoV-2 infections are occurring in
vaccinated and naturally infected populations. While humoral and cellular responses in COVID-…
vaccinated and naturally infected populations. While humoral and cellular responses in COVID-…
Prevalence of antibiotic resistance over time in a third-level University Hospital
…, M Mazzitelli, F Serapide, R Lionello… - Microbial Drug …, 2022 - liebertpub.com
This study evaluated the spread and possible changes in resistance patterns of ESKAPE
bacteria to first-choice antibiotics from 2015 to 2019 at a third-level university hospital after …
bacteria to first-choice antibiotics from 2015 to 2019 at a third-level university hospital after …
[HTML][HTML] Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study
…, S Rotundo, N Marascio, C De Marco, R Lionello… - BMC Infectious …, 2022 - Springer
Background Monoclonal antibodies (mAbs) and antivirals have been approved for early therapy
of coronavirus disease (COVID-19), however, in the real-life setting, there are difficulties …
of coronavirus disease (COVID-19), however, in the real-life setting, there are difficulties …
[HTML][HTML] Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: A single-centre real-world experience
…, F Divenuto, F Serapide, A Bruni, R Lionello… - BMC Infectious …, 2022 - Springer
Background T2Dx was approved by the US Food and Drug Administration for the rapid detection
of a modified panel of ESKAPE bacterial species or Candida spp. causing bloodstream …
of a modified panel of ESKAPE bacterial species or Candida spp. causing bloodstream …
Characteristics, outcome and predictors of in-hospital mortality in an elderly population from a SARS-CoV-2 outbreak in a long-term care facility
…, G Perri, P Fusco, V Scaglione, C Davoli, R Lionello… - medRxiv, 2020 - medrxiv.org
Since December 2019, coronavirus disease 2019 (COVID-19) pandemic has spread from
China all over the world, many COVID-19 outbreaks have been reported in long-term care …
China all over the world, many COVID-19 outbreaks have been reported in long-term care …
[HTML][HTML] Interleukin-62/lymphocyte as a proposed predictive index for COVID-19 patients treated with monoclonal antibodies
In a convenience sample of 93 patients treated with monoclonal antibodies (moAbs) against
SARS-CoV-2, the interleukin-6 2 /lymphocyte count ratio (IL-6 2 /LC) was able to predict …
SARS-CoV-2, the interleukin-6 2 /lymphocyte count ratio (IL-6 2 /LC) was able to predict …